Document Detail

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
MedLine Citation:
PMID:  19195508     Owner:  NLM     Status:  MEDLINE    
Drug-eluting stent (DES) implantation is the standard treatment for patients with bare-metal stent (BMS) in-stent restenosis (ISR) and is associated with low rates of target-vessel revascularization. Outcomes in patients with DES ISR treated using repeated DES placement are less certain. A total of 119 patients who presented with BMS ISR and 119 patients with DES ISR matched for baseline characteristics were evaluated. Both groups of patients were treated using DESs and compared with regard to major adverse cardiac events, including death, myocardial infarction, and target-vessel revascularization, at 1 year. Baseline characteristics were similar between groups. Compared with patients with BMS ISR, those with DES ISR had similar 1-year rates of death (5.1% BMS ISR vs 3.5% DES ISR; p = 0.75) and myocardial infarction (2.6% BMS ISR vs 3.5% DES ISR; p = 0.72) when treated using DESs. However, at 1 year, patients with DES ISR experienced significantly higher rates of target-vessel revascularization (10.3% BMS ISR vs 22.2% DES ISR; p = 0.01), with a trend toward increased overall major adverse cardiac events, including death, myocardial infarction, and target-vessel revascularization (16.0% BMS ISR vs 25.2% DES ISR; p = 0.08). Stent thrombosis occurred with similar frequency in both groups (2.5% BMS ISR vs 0.8% DES ISR; p = 0.62). In conclusion, DES ISR continues to be a therapeutic challenge because patients with DES ISR treated using DESs experience higher rates of recurrence compared with patients with BMS ISR treated using DESs. The optimal treatment of patients with DES restenosis remains to be defined.
Daniel H Steinberg; Michael A Gaglia; Tina L Pinto Slottow; Probal Roy; Laurent Bonello; Axel De Labriolle; Gilles Lemesle; Rebecca Torguson; Kimberly Kineshige; Zhenyi Xue; William O Suddath; Kenneth M Kent; Lowell F Satler; Augusto D Pichard; Joseph Lindsay; Ron Waksman
Related Documents :
21542698 - Development of myocardial constructs using modulus-matched acrylated polypropylene glyc...
20659948 - Paclitaxel-coated balloon versus drug-eluting stent during pci of small coronary vessel...
12032478 - Mechanisms of myocardial hypoperfusion during rotational atherectomy of de novo coronar...
12607658 - Clinical impact of drug-eluting stents in changing referral practices for coronary surg...
21478128 - False perfusion defect on myocardial perfusion spect induced by sternal tumoral uptake.
10455308 - Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  103     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-06     Completed Date:  2009-03-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  491-5     Citation Subset:  AIM; IM    
Department of Internal Medicine, Washington Hospital Center, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Artery Disease / therapy*
Coronary Restenosis*
Drug-Eluting Stents*
Middle Aged
Retrospective Studies
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predictors of inpatient outcomes in hospitalized patients after left heart catheterization.
Next Document:  Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left an...